Domestic Animal Endocrinology
Volume 38, Issue 4 , Pages 260-271 , May 2010

Expression of leukemia inhibitory factor and leukemia inhibitory factor receptor in the canine pituitary gland and corticotrope adenomas

Received 24 April 2009 ,Revised 2 November 2009 ,Accepted 20 November 2009.

References 

  1. Rijnberk A. Adrenals. In:  Rijnberk A editors. Clinical Endocrinology of Dogs and Cats. Dordrecht: Kluwer Academic Publishers; 1996;p. 61–93
  2. Auernhammer CJ, Melmed S. Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr Rev. 2000;21:313–345
  3. Metcalf D. The unsolved enigmas of leukemia inhibitory factor. Stem Cells. 2003;21:5–14
  4. Akita S, Webster J, Ren SG, Takino H, Said J, Zand O, et al. Human and murine pituitary expression of leukemia inhibitory factor: novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J Clin Invest. 1995;95:1288–1298
  5. Ray DW, Ren SG, Melmed S. Leukemia inhibitory factor regulates proopiomelanocortin transcription. Ann N Y Acad Sci. 1998;840:162–173
  6. Akita S, Readhead C, Stefaneanu L, Fine J, Tampanaru-Sarmesiu A, Kovacs K, et al. Pituitary-directed leukemia inhibitory factor transgene forms Rathke's cleft cysts and impairs adult pituitary function. A model for human pituitary Rathke's cysts. J Clin Invest. 1997;99:2462–2469
  7. Yano H, Readhead C, Nakashima M, Ren SG, Melmed S. Pituitary-directed leukemia inhibitory factor transgene causes cushing's syndrome: neuro-immune-endocrine modulation of pituitary development. Mol Endocrinol. 1998;12:1708–1720
  8. Zhang JG, Zhang Y, Owczarek CM, Ward LD, Moritz RL, Simpson RJ, et al. Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor alpha-chain in normal human urine and plasma. J Biol Chem. 1998;273:10798–10805
  9. Layton MJ, Cross BA, Metcalf D, Ward LD, Simpson RJ, Nicola NA. A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor. Proc Natl Acad Sci U S A. 1992;89:8616–8620
  10. Ray DW, Ren SG, Melmed S. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line: role of STAT pathway. J Clin Invest. 1996;97:1852–1859
  11. Bousquet C, Ray DW, Melmed S. A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy. J Biol Chem. 1997;272:10551–10557
  12. Bousquet C, Melmed S. Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling. J Biol Chem. 1999;274:10723–10730
  13. Bousquet C, Zatelli MC, Melmed S. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. J Clin Invest. 2000;106:1417–1425
  14. Mynard V, Guignat L, Devin-Leclerc J, Bertagna X, Catelli MG. Different mechanisms for leukemia inhibitory factor-dependent activation of two proopiomelanocortin promoter regions. Endocrinology. 2002;143:3916–3924
  15. Latchoumanin O, Mynard V, Devin-Leclerc J, Dugue MA, Bertagna X, Catelli MG. Reversal of glucocorticoids-dependent proopiomelanocortin gene inhibition by leukemia inhibitory factor. Endocrinology. 2007;148:422–432
  16. Heutling D, Dieterich KD, Buchfelder M, Lehnert H. Mutation analysis of leukemia inhibitory factor-receptor (LIF-R) in ACTH-secreting pituitary adenomas. Exp Clin Endocrinol Diabetes. 2004;112:458–461
  17. Shimon I, Yan X, Ray DW, Melmed S. Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. J Clin Invest. 1997;100:357–363
  18. Hanson JM, van’t Hoofd MM, Voorhout G, Teske E, Kooistra HS, Meij BP. Efficacy of transsphenoidal hypophysectomy in treatment of dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med. 2005;19:687–694
  19. Bosje JT, Rijnberk A, Mol JA, Voorhout G, Kooistra HS. Plasma concentrations of ACTH precursors correlate with pituitary size and resistance to dexamethasone in dogs with pituitary-dependent hyperadrenocorticism. Domest Anim Endocrinol. 2002;22:201–210
  20. Rijnberk A, Mol JA, Rothuizen J, Bevers MM, Middleton DJ. Circulating pro-opiomelanocortin-derived peptides in dogs with pituitary-dependent hyperadrenocorticism. Front Horm Res. 1987;17:48–60
  21. van der Vlugt-Meijer RH, Voorhout G, Meij BP. Imaging of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. Mol Cell Endocrinol. 2002;197:81–87
  22. Voorhout G, Rijnberk A, Sjollema BE, van den Ingh TSGAM. Nephrotomography and ultrasonography for the localization of hyperfunctioning adrenocortical tumors in dogs. Am J Vet Res. 1990;51:1280–1285
  23. Hanson JM, Mol JA, Leegwater PA, Kooistra HS, Meij BP. The leukemia inhibitory factor receptor gene is not involved in the etiology of pituitary dwarfism in German shepherd dogs. Res Vet Sci. 2006;81:316–320
  24. Aasland D, Schuster B, Grotzinger J, Rose-John S, Kallen KJ. Analysis of the leukemia inhibitory factor receptor functional domains by chimeric receptors and cytokines. Biochemistry. 2003;42:5244–5252
  25. Brinkhof B, Spee B, Rothuizen J, Penning LC. Development and evaluation of canine reference genes for accurate quantification of gene expression. Anal Biochem. 2006;356:36–43
  26. Hanson JM, Mol JA, Leegwater PA, Bilodeau S, Drouin J, Meij BP. Expression and mutation analysis of Tpit in the canine pituitary gland and corticotroph adenomas. Domest Anim Endocrinol. 2008;34:217–222
  27. Muller PY, Janovjak H, Miserez AR, Dobbie Z. Processing of gene expression data generated by quantitative real-time rt-PCR. Biotechniques. 2002;32:1372–13741376, 1378-1379
  28. Kontogeorgos G, Patralexis H, Tran A, Kovacs K, Melmed S. Expression of leukemia inhibitory factor in human pituitary adenomas: a morphologic and immunocytochemical study. Pituitary. 2000;2:245–251
  29. Wang Z, Ren SG, Melmed S. Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: A novel endotoxin-inducible neuro-endocrine interface. Endocrinology. 1996;137:2947–2953
  30. Catania A, Airaghi L, Colombo G, Lipton JM. Alpha-melanocyte-stimulating hormone in normal human physiology and disease states. Trends Endocrinol Metab. 2000;11:304–308
  31. Cragnolini AB, Caruso C, Lasaga M, Scimonelli TN. Alpha-MSH and gamma-MSH modulate early release of hypothalamic pge2 and no induced by IL-1beta differently. Neurosci Lett. 2006;409:168–172
  32. Gadd SL, Clevenger CV. Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications. Mol Endocrinol. 2006;20:2734–2746
  33. Levine SJ. Mechanisms of soluble cytokine receptor generation. J Immunol. 2004;173:5343–5348
  34. Wang Z, Melmed S. Identification of an upstream enhancer within a functional promoter of the human leukemia inhibitory factor receptor gene and its alternative promoter usage. J Biol Chem. 1997;272:27957–27965
  35. Dorval-Coiffec I, Delcros JG, Hakovirta H, Toppari J, Jegou B, Piquet-Pellorce C. Identification of the leukemia inhibitory factor cell targets within the rat testis. Biol Reprod. 2005;72:602–611
  36. Blanchard F, Duplomb L, Wang Y, Robledo O, Kinzie E, Pitard V, et al. Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase. J Biol Chem. 2000;275:28793–28801
  37. Judd LM, Bredin K, Kalantzis A, Jenkins BJ, Ernst M, Giraud AS. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology. 2006;131:1073–1085
  38. Tighe AP, Gudas LJ. Retinoic acid inhibits leukemia inhibitory factor signaling pathways in mouse embryonic stem cells. J Cell Physiol. 2004;198:223–229
  39. Paez-Pereda M, Kovalovsky D, Hopfner U, Theodoropoulou M, Pagotto U, Uhl E, et al. Retinoic acid prevents experimental Cushing syndrome. J Clin Invest. 2001;108:1123–1131
  40. Castillo V, Giacomini D, Paez-Pereda M, Stalla J, Labeur M, Theodoropoulou M, et al. Retinoic acid as a novel medical therapy for Cushing's disease in dogs. Endocrinology. 2006;147:4438–4444

PII: S0739-7240(09)00148-9

doi: 10.1016/j.domaniend.2009.11.005

Domestic Animal Endocrinology
Volume 38, Issue 4 , Pages 260-271 , May 2010

Article Tools

* Image Usage & Resolution